Manifold Bio • High Throughput In Vivo Drug Design
manifold.bio · 930 words · saved by 2 readers
Our innovative technology combines protein barcoding and high-throughput in vivo capabilities to design drugs with more precise molecular testing.
Manifold Bio | Tissue-targeted medicines, designed in vivo MANIFOLD BIO DEMONSTRATES MILLION-SCALE EXPERIMENTAL VALIDATION OF AI-DRIVEN PROTEIN BINDER DESIGN WITH NVIDIA Skip to Main Content Organism-scale intelligence, designed in vivo Manifold Bio has built the first high-throughput in vivo discovery engine—combining massively multiplexed in vivo screening and AI-powered design to create tissue-targeted biologics while building the virtual organism. Learn More the challenge In vitro is not in vivo Even the best AI models can only optimize for the context they are trained on. In vitro assays
saved by
related reading
- AlphaProteo generates novel proteins for biology and health researchdeepmind.google
- AI-Powered Drug Discovery Platform | Deep Origindeeporigin.com
- Convoke | Biopharma's Operating Systemconvoke.bio
- Gap Mapgap-map.org
- One-shot design of functional protein binders with BindCraftnature.com
- Protein World Model | Biohubbiohub.ai
- Proto: A programming language for generative biology | Arc Institutearcinstitute.org
- Self-driving laboratories to autonomously navigate the protein fitness landscapenature.com
- Topos Bio - Redefining Druggable Spacetoposbio.ai
- Pumpkinseed | The Biology Mining Company | Proteomic data infrastructure for bio-AIpumpkinseed.bio
- Ludovico Comitoludocomito.dev
- Asimov — Intelligent Designasimov.com